title: Detrimental effect of atazanavir plasma concentrations on total serum bilirubin levels in the presence of UGT1A1 polymorphisms.
authors.forename: Paola
authors.initials: P
authors.lastname: Cicconi
authors.forename: Teresa
authors.initials: T
authors.lastname: Bini
authors.forename: Alessandra
authors.initials: A
authors.lastname: Barassi
authors.forename: Maddalena
authors.initials: M
authors.lastname: Casana
authors.forename: Olivia
authors.initials: O
authors.lastname: Turri
authors.forename: Francesca
authors.initials: F
authors.lastname: Pateri
authors.forename: Giulia C
authors.initials: GC
authors.lastname: Marchetti
authors.forename: Maria Luisa
authors.initials: ML
authors.lastname: Biondi
authors.forename: Gianlodovico Melzi
authors.initials: GM
authors.lastname: d'Eril
authors.forename: Antonella
authors.initials: A
authors.lastname: d'Arminio Manforte
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects*; D000069446:Atazanavir Sulfate; D001663:Bilirubin / Q000097:blood*; D005260:Female; D014453:Glucuronosyltransferase / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000009:adverse effects*; D010949:Plasma / Q000737:chemistry*; D011110:Polymorphism, Genetic; D011725:Pyridines / Q000009:adverse effects*; D000099148:UGT1A1 Enzyme
chemical_list: D019380:Anti-HIV Agents; D000069446:Atazanavir Sulfate; D001663:Bilirubin; D014453:Glucuronosyltransferase; D009842:Oligopeptides; D011725:Pyridines; D000099148:UGT1A1 Enzyme